Trelegy Ellipta Powder for inhalation (Fluticasone Furoate (100mcg), Umeclidinium (62.5mcg) and Vilanterol (25mcg))
Reliable shipping
Flexible returns
Trelegy Ellipta is a prescription medication designed for the once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. This inhalation powder combines three active ingredients: Fluticasone Furoate, Umeclidinium, and Vilanterol, each playing a crucial role in managing respiratory conditions.
Fluticasone Furoate is a corticosteroid that helps reduce inflammation in the airways, improving breathing and reducing the frequency of asthma attacks. Umeclidinium is a long-acting muscarinic antagonist (LAMA) that aids in relaxing the muscles around the airways, further facilitating easier airflow. Vilanterol is a long-acting beta-agonist (LABA) that helps open the airways, providing relief from breathing difficulties.
Trelegy Ellipta is delivered via a convenient inhaler, ensuring that patients receive the precise dosage of medication directly to their lungs. The inhaler is designed for ease of use, with a built-in dose counter to help track remaining doses. This feature supports adherence to the treatment regimen, which is essential for managing chronic respiratory conditions effectively.
Patients using Trelegy Ellipta may experience improved lung function, reduced breathlessness, and fewer flare-ups of their condition. It is important for users to follow their healthcare provider's instructions regarding usage and to attend regular check-ups to monitor their condition.
As with any medication, Trelegy Ellipta may cause side effects. Common side effects include headache, sore throat, and upper respiratory tract infections. Patients should be aware of potential serious side effects and consult their healthcare provider if they experience symptoms such as chest pain, increased heart rate, or signs of an allergic reaction.
Overall, Trelegy Ellipta is a comprehensive treatment option for individuals with COPD and asthma, designed to enhance quality of life and facilitate better respiratory health.
- Fluticasone Furoate (100 mcg)
- Umeclidinium (62.5 mcg)
- Vilanterol (25 mcg)
Trelegy Ellipta is a prescription medication used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It combines three active ingredients: Fluticasone Furoate, Umeclidinium, and Vilanterol, which work together to help improve breathing. Follow these detailed instructions to use the inhaler safely and effectively.
Before using the inhaler, wash your hands thoroughly with soap and water to ensure they are clean.
Open the inhaler by sliding the cover down until it clicks. This action will prepare the inhaler for use.
Hold the inhaler upright with the mouthpiece facing you. Avoid touching the hole at the mouthpiece to prevent contamination.
Take a deep breath and exhale completely to empty your lungs. This will help you take a more effective dose.
Place the mouthpiece between your lips and close your lips around it, ensuring a tight seal.
While taking a slow, deep breath in through your mouth, press down on the lever to release the medication. Continue to breathe in slowly and deeply.
After inhaling the medication, remove the inhaler from your mouth and hold your breath for about 10 seconds. This allows the medication to settle in your lungs.
Exhale gently. You may want to wait a few moments before taking any additional doses, if prescribed.
Close the inhaler by sliding the cover back up until it clicks, which protects the mouthpiece from dirt and damage.
Rinse your mouth with water after using the inhaler to minimize the risk of oral thrush and other side effects. Do not swallow the water.
Store the inhaler in a cool, dry place, away from direct sunlight. Do not store it in a bathroom or humid area.
Always follow your healthcare provider's instructions regarding dosage and frequency of use. If you experience any side effects or have questions about using Trelegy Ellipta, consult your doctor or pharmacist for guidance.